Comparative Study of Thuja Internal vs. Local Application For treating the patients of Warts

Comparative study of Thuja - Internal and local application in cases of Warts. - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/12/078770

Enrollment

Registered

2024-12-30

Start date

Unknown

Completion date

Unknown

Last updated

2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

Intervention1: Homoeopathic medicine THUJA will be given to one group: Cases where Thuja is indicated will be given internally in different potencies like 30, 200 and 1M depending upon the susceptibil

Eligibility

Inclusion criteria

Inclusion criteria: Cases with Warts will be selected irrespective of age and gender. previously surgically treated Warts will be taken.

Exclusion criteria

Exclusion criteria: Cases with irreversible pathological changes. Cases with genital warts. Cases with malignant changes. Cases with irregular follow ups. Cases can withdraw their consent anytime during the course of the study.

Design outcomes

Primary

Measure	Time frame
To study the effectiveness of Thuja in cases of wartsTimepoint: Homoeopathic Medicine Dose As per Requirement of case through Sublingual Mode of Administration within Time Duration of 9 Months	—

Secondary

Measure	Time frame
To study effectiveness of Thuja medicine as internal medicine and external applicationTimepoint: 9 months	—

Countries

India

Contacts

Public ContactDr Diti Jayeshbhai Patel

C D Pachchigar College of Homoeopathic Medicine and Hospital

rajeshmahale4u@gmail.com9825290925

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026